Likewise, there was no significant association between CD34+ dose and moderate to severe chronic GVHD when CD34+ cell dose was used as a continuous variable (HR = 1.02 [0.99–1.06], p = 0.21). Here, CD34 is linked to chronic graft versus host disease.